SEC Form 4 · accession 0001675628-26-000002
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Titus B. Ball
Officer — Principal Accounting Officer
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 5:55 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jun 11, 2026 | A | 31,213 | $0.00 | A | 99,645 | D | |
| American Depositary SharesF2 | Jun 11, 2026 | S | 49 | $256.387 | D | 120 | D | |
| American Depositary SharesF2 | Jun 11, 2026 | S | 120 | $257.53 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F2Each American Depositary Share represents 13 Ordinary Shares.
- F3The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service.